The Development of Psychiatric Illness and Chemoprophylaxis of Botulinum Toxin in Migraine: A Narrative Review
- PMID: 36712737
- PMCID: PMC9879228
- DOI: 10.7759/cureus.32998
The Development of Psychiatric Illness and Chemoprophylaxis of Botulinum Toxin in Migraine: A Narrative Review
Abstract
A migraine is not just a headache. It is an extremely prevalent neurological condition marked by periodic episodes of unilateral headache, with more than 10 million cases yearly. Migraine often begins at the age of puberty. It substantially impacts the brain and, consequently, psychiatric behavior linked with frequent migraine attacks that may be moderate to severe in intensity. A crucial aspect of migraine variability is comorbidity with other neurological diseases, vascular diseases, and mental illnesses. Psychiatric disorders related to migraine include anxiety disorders, panic disorder, bipolar disorder, depression, etc. It is also estimated that people suffering from migraine are about five times more likely to develop depression than others without migraine. The stimulus for migraine is stress, lack of sleep, skipped meal or fasting, visual stimulation due to high intensity of light, auditory stimulus due to noise, and olfactory stimulus due to a pungent smell. A majority of patients suffer from migraine attacks triggered by noise, some due to visual stimulation, and a few due to perfumes or other odors that trigger their migraine. Diagnosis of this is primarily dependent on history taking and clinical evaluation. Migraine can be classified depending on whether an aura is present or absent. It can further be divided based on the frequency of headaches into episodic migraine or chronic migraine, which may be determined by the duration of the headache. The development of migraine is influenced by both genetics and the environment. It has a detrimental effect on children's quality of life. A comprehensive analysis of psychiatric illnesses in migraine contributes to early diagnosis and proper treatment of the disease. Also, having a healthy lifestyle (including exercise, a balanced diet, and enough sleep) seems to prevent and improve the condition. Headache in migraine is resistant to medical treatment but responds well to botulinum toxin. This review primarily focuses on the psychiatric issues like depression and anxiety that often accompany migraine. The article also highlights the effects of botulinum toxin on migraine.
Keywords: anxiety disorder; auditory stimulus; bipolar disorder; chronic migraine; dementia; depression; episodic migraine; panic disorder; stress; visual stimulus.
Copyright © 2022, Dhengare et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Botulinum toxin in migraine prophylaxis.J Neurol. 2004 Feb;251 Suppl 1:I8-11. doi: 10.1007/s00415-004-1103-y. J Neurol. 2004. PMID: 14991336 Review.
-
Sleep-related headache and its management.Curr Treat Options Neurol. 2013 Dec;15(6):704-22. doi: 10.1007/s11940-013-0258-1. Curr Treat Options Neurol. 2013. PMID: 24132786
-
Impact of Pre-Existing Migraine and Other Co-Morbid or Co-Occurring Conditions on Presentation and Clinical Course Following Deployment-Related Concussion.Headache. 2020 Mar;60(3):526-541. doi: 10.1111/head.13709. Epub 2020 Jan 3. Headache. 2020. PMID: 31898813
-
The Development and Impact of Anxiety With Migraines: A Narrative Review.Cureus. 2022 Jun 29;14(6):e26419. doi: 10.7759/cureus.26419. eCollection 2022 Jun. Cureus. 2022. PMID: 35923673 Free PMC article. Review.
-
Sleep disturbance and affective comorbidity among episodic migraineurs.Headache. 2014 Jan;54(1):116-24. doi: 10.1111/head.12168. Epub 2013 Jun 28. Headache. 2014. PMID: 23808359
Cited by
-
Advances in Migraine Treatment: A Comprehensive Clinical Review.Curr Protein Pept Sci. 2025;26(6):422-435. doi: 10.2174/0113892037329429241123095325. Curr Protein Pept Sci. 2025. PMID: 39810518 Review.
References
-
- Migraine. Silberstein SD. Lancet. 2004;363:381–391. - PubMed
-
- Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications. Baskin SM, Smitherman TA. Neurol Sci. 2009;30:0–5. - PubMed
-
- Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention. Lipton RB, Silberstein SD. Headache. 2015;55:103–122. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous